Pharmaceutical Import Export Data 2025: Top Medicine Importing Countries and Buyers
Medicines are one of the most valuable products in world trade, and demand keeps rising. In 2025, countries imported finished medicines worth $594.1 billion, up 10.9% from the year before. Most of this money comes from a small group of rich markets: the United States, Germany, France, Italy, the United Kingdom, Spain, Japan and Canada. In this guide, you will see which countries import the most medicines, how fast each market is growing, who supplies them, and how pharma exporters can use import export data to find real buyers in these high-value markets.
Pharmaceutical Import Export Data 2025 at a Glance
This guide covers finished medicines under HS codes 3003 and 3004, meaning medicaments ready for sale in measured doses or bulk form. Here are the key 2025 numbers, based on Trade Map and UN Comtrade statistics:
- World medicine imports: $594.1 billion, up 10.9% from $535.6 billion in 2024.
- World medicine exports: $560.2 billion.
- The top 15 importing countries take 70.8% of all imports.
- Eight major economies, the US, Germany, France, Italy, the UK, Spain, Japan and Canada, are all in the top 15.

What this means for business: buying power in pharma is highly concentrated. If you win distributors or wholesalers in just a few of these countries, you reach most of the world’s demand. That is why serious exporters focus on the top markets first. These markets also tend to buy in large volumes and stay with suppliers who deliver consistent quality year after year.
Top 15 Medicine Importing Countries in 2025
| Rank | Country | Import Value 2025 | Share of World Imports |
|---|---|---|---|
| 1 | United States | $96.56B | 16.3% |
| 2 | Switzerland | $55.72B | 9.4% |
| 3 | Germany | $43.67B | 7.4% |
| 4 | Belgium | $41.55B | 7.0% |
| 5 | France | $23.79B | 4.0% |
| 6 | China | $23.62B | 4.0% |
| 7 | Italy | $21.66B | 3.6% |
| 8 | United Kingdom | $20.52B | 3.5% |
| 9 | Spain | $20.11B | 3.4% |
| 10 | Japan | $15.72B | 2.6% |
| 11 | Ireland | $15.10B | 2.5% |
| 12 | Netherlands | $11.87B | 2.0% |
| 13 | Canada | $11.14B | 1.9% |
| 14 | Slovenia | $10.15B | 1.7% |
| 15 | Poland | $9.62B | 1.6% |
The United States alone imports almost as much as Switzerland and Germany combined. Switzerland, Belgium, Ireland and Slovenia are big importers mainly because global drug companies run production and distribution hubs there. They buy, process and re-export. For a new exporter looking for end-market buyers, the eight large consumer markets on this list are usually the better first targets.
8 Key Target Markets for Medicine Exporters

| Market | Import Value 2025 | Share | Change Since 2021 |
|---|---|---|---|
| United States | $96.56B | 16.3% | +13.3% |
| Germany | $43.67B | 7.4% | +26.9% |
| France | $23.79B | 4.0% | +31.5% |
| Italy | $21.66B | 3.6% | +23.0% |
| United Kingdom | $20.52B | 3.5% | +37.9% |
| Spain | $20.11B | 3.4% | +62.9% |
| Japan | $15.72B | 2.6% | -15.7% |
| Canada | $11.14B | 1.9% | +16.9% |
United States ($96.56B): the largest medicine market in the world, with about one in every six dollars of global imports. Demand for generic medicines is very strong, which is why exporters from India and Europe compete hard here.
Germany ($43.67B): both a top buyer and the world’s biggest exporter. Many German importers are wholesalers and pharma companies that serve the wider European market, so one German partner can open several countries.
France, Italy and the United Kingdom ($20-24B each): steady, high-value markets with large and stable demand for medicines. Imports grew 31.5% in France and 37.9% in the UK since 2021.
Spain ($20.11B): the fastest-growing big market on this list, with imports up 62.9% since 2021. That makes it one of the most interesting targets for new suppliers.
Japan ($15.72B): a large, quality-focused market. Imports are lower than in 2021, so exporters need a clear quality and price advantage to win share.
Canada ($11.14B): a stable market that grew 16.9% and is often served alongside the United States.
Other large economies such as South Korea, Australia, Mexico, Brazil and Russia are not in the top 15 for finished medicines, but they are still sizeable markets and good targets for a second phase of expansion.
Who Supplies These Markets: Top Medicine Exporters

| Rank | Exporter | Export Value 2025 | Share |
|---|---|---|---|
| 1 | Germany | $73.34B | 13.1% |
| 2 | Italy | $55.90B | 10.0% |
| 3 | Switzerland | $50.91B | 9.1% |
| 4 | Ireland | $40.89B | 7.3% |
| 5 | Belgium | $40.02B | 7.1% |
| 6 | United States | $35.81B | 6.4% |
| 7 | France | $34.05B | 6.1% |
| 8 | Slovenia | $31.99B | 5.7% |
| 9 | Netherlands | $23.24B | 4.1% |
| 10 | India | $22.98B | 4.1% |
European countries dominate the supply side. India ranks 10th with $22.98 billion, and it is the leading supplier from outside Europe and the United States, mostly through affordable generic medicines. For Indian and other Asian exporters, this shows both the size of the competition and the room still left to grow in the big Western markets.
Export data on these supplier countries is just as useful as import data on the buyers. It shows which products each competing country ships, to which markets and at what average price. If German or Italian suppliers dominate a product in Spain, for example, a lower-cost exporter can position itself as a second source. If Indian generics already sell well in the US, the same importers may be open to new products from a similar supplier.
Trends and Opportunities from the Global Data
The global data points to several clear trends:
- Demand keeps climbing: world medicine imports grew 10.9% in a single year and 28.2% since 2021.
- Spain and the UK are booming: imports grew 62.9% in Spain and 37.9% in the UK since 2021, much faster than the world average.
- Generic medicines win on price: large buyers in the US and Europe keep looking for reliable, lower-cost suppliers.
- Hub countries matter: Belgium, Switzerland, Ireland and the Netherlands move large volumes through regional distribution centres.
- Japan needs a different plan: falling imports mean exporters must compete on quality and specialised products.
How to Find Pharma Buyers with Import Export Data
Country totals tell you where to look. Shipment-level import export data tells you who to call. With detailed records you can:
- Find active importers of your exact product by HS code (for example 3004) in the US, Germany, Spain or any target market.
- See who they buy from today, so you know which suppliers you are up against.
- Benchmark prices using declared values and quantities, and set a competitive offer.
- Track order frequency to spot importers with steady, repeat demand.
- Spot new buyers early by watching monthly import data for new names in your product line.
For a pharma exporter, this turns a long list of countries into a short list of real companies to contact. A simple approach works well: pick two or three target markets from the table above, pull the importers of your HS code in each one, rank them by volume and order frequency, and then check which suppliers they use today. Within a few days, you have a focused buyer list instead of a guess. Explore the full list of countries covered by DataVault Insights to find buyer data for the US, Europe, Japan and other target markets.
Conclusion
Finished medicines are a $594 billion import market, and the United States, Germany, France, Italy, the United Kingdom, Spain, Japan and Canada account for more than 40% of it. Demand is rising, Spain and the UK are growing fast, and buyers keep looking for reliable, cost-effective suppliers. To find the actual importers, distributors and shipment details in these markets, visit DataVault Insights and start building your buyer list with real import export data.